Article Figures & Data
Figures
- Figure 1.
Study Design of LIRA-ADD2BASAL
BMI, body mass index.
Reproduced with permission from J Lahtela, MD.
- Figure 2.
Change in HbA1c in Patients Taking Liraglutide Versus Placebo Added to Basal Insulin Analogs
Estimated means ± standard errors, from mixed model for repeated measurements. ETD, estimated treatment difference.
Reproduced with permission from J Lahtela, MD.
a95% CI, −1.39 to −0.99 (P < .0001).
- Figure 3.
Change in Weight in Patients Taking Liraglutide Versus Placebo Added to Basal Insulin Analogs
Estimated mean change from baseline to week 26, from mixed model for repeated measurements. ETD, estimated treatment difference.
Reproduced with permission from J. Lahtela, MD.
a95% CI, −3.85 to −2.37 (P < .0001).
Tools
LIRA-ADD2BASAL: Liraglutide Added to Basal Insulin Analogs Improves Glycemic Control
Permalink:
Table of contents
Cited By...
- No citing articles found.